depression
14 interactions related to depression
fluoxetine + sam-e
SAM-e has its own serotonergic and mood-elevating activity, so combining it with fluoxetine can add to your overall serotonin tone. In theory this can raise the risk of serotonin syndrome, and in vulnerable people it can tip mood into hypomania or mania. Because fluoxetine clears slowly, this caution lingers for weeks after the last dose. The evidence is mostly case reports involving other antidepressants and general guidance about combining SAM-e with serotonin-raising drugs, rather than fluoxetine-specific data.
fluoxetine + saffron
Saffron (Crocus sativus) has its own mild antidepressant activity, including serotonergic effects shown in randomized controlled trials. Combining a standardized saffron extract with fluoxetine theoretically adds to serotonergic tone, but augmentation trials adding saffron on top of existing antidepressants found it well tolerated, with no reported cases of serotonin syndrome. The interaction is best treated as plausible rather than documented.
maoi + tyramine foods
Monoamine oxidase inhibitors block MAO-A in the gut and liver, the enzyme that normally breaks down dietary tyramine. Unmetabolized tyramine triggers a surge of stored norepinephrine, which can produce a hypertensive crisis (the 'cheese reaction') with severe blood pressure spikes, headache, and in serious cases stroke or death.
maoi + st. john's wort
St. John's Wort raises brain serotonin, norepinephrine, and dopamine through reuptake inhibition and shows weak monoamine oxidase inhibition. Layered on a prescription MAOI, which blocks the breakdown of those same monoamines, the combination can push monoamine signaling to dangerous levels and is contraindicated because of the risk of serotonin syndrome and hypertensive crisis.
maoi + 5-htp
5-HTP is the direct precursor to serotonin and bypasses the rate-limiting step of serotonin synthesis. Combined with an MAOI, which blocks serotonin breakdown, serotonin can rise to dangerous levels and trigger serotonin syndrome, a potentially life-threatening reaction.
saffron + antidepressants
Saffron's active constituents (crocin and safranal) show antidepressant-like activity in laboratory and animal studies, partly through monoamine reuptake and monoamine-oxidase inhibition. This overlaps with how SSRIs, SNRIs, and MAOIs work, raising a theoretical concern about additive serotonergic effects. In practice, human trials combining standardized saffron with fluoxetine or sertraline reported no serotonin syndrome and no serious adverse events, and there are no documented human cases from this combination.
alcohol + venlafaxine
Venlafaxine (Effexor) is an SNRI antidepressant, and alcohol is a central nervous system depressant. The FDA-approved label advises avoiding alcohol because the combination can add to drowsiness and dizziness and can worsen the mood or anxiety disorder being treated. The concern is about additive sedation, blood pressure, and undermined treatment rather than a dramatic pharmacokinetic clash, which is why it is rated moderate.
alcohol + duloxetine
Duloxetine (Cymbalta) can occasionally cause liver injury, and its FDA label advises against prescribing it to people with substantial or chronic alcohol use or existing liver disease, because both substances stress the liver. Documented cases have generally been reversible after stopping the drug, with no clear pattern of alcohol-linked liver failure in the published case series.
sertraline + sam-e
SAM-e (S-adenosyl-L-methionine) has its own antidepressant and serotonergic activity, so combining it with the SSRI sertraline can add serotonergic effects on top of each other. Case reports describe serotonin-toxicity-like presentations and treatment-emergent mania in patients combining SAM-e with serotonergic antidepressants.
bupropion + st. john's wort
St. John's wort induces drug-metabolizing enzymes that can lower bupropion blood levels and weaken its effect. A human case report also links the pair to a prolonged movement (dystonic) reaction from overlapping effects on brain chemicals. The often-cited additive seizure risk rests mainly on animal extract studies and is not well supported in people.
alcohol + sertraline
Sertraline (Zoloft) and alcohol both act on the central nervous system. Controlled studies in healthy volunteers did not show sertraline worsening alcohol's effects on thinking or coordination, but the FDA label still advises against drinking on sertraline because alcohol can deepen depression and anxiety, worsen drowsiness and sleep, and blunt the medication's benefit in people being treated for a mood disorder.
alcohol + fluoxetine
Fluoxetine (Prozac) is an SSRI antidepressant, and alcohol is a central nervous system depressant. The FDA-approved Prozac label states that alcohol use is not recommended while taking fluoxetine. Fluoxetine and its active metabolite norfluoxetine also have unusually long half-lives, so the drug stays in your system for weeks once you reach steady state — there is no simple "timing window" that avoids the interaction. Notably, a controlled human study found that alcohol did not measurably increase fluoxetine's psychomotor impairment, so the combined sedative effect is more modest than once assumed; the precaution remains sensible but is not an emergency.
fermented foods + maois
Fermented foods accumulate tyramine when bacteria break down the amino acid tyrosine during fermentation. MAOIs block the monoamine oxidase enzyme that normally clears dietary tyramine in the gut wall and liver, so the tyramine reaches the bloodstream and triggers a surge of norepinephrine. This can produce a sudden, dangerous rise in blood pressure (a hypertensive crisis).
saffron + curcumin
Saffron (Crocus sativus) and curcumin (from turmeric) both have antidepressant effects through partly complementary mechanisms: saffron modulates serotonin and dopamine reuptake and increases BDNF, while curcumin reduces neuroinflammation, supports monoamine balance, and normalizes the HPA axis. A randomized, double-blind, placebo-controlled trial found a saffron plus curcumin combination significantly improved depressive symptoms versus placebo in adults with major depression.